Latest Asx News

Electro Optic Systems (ASX:EOS) has dramatically expanded its Share Purchase Plan from $25 million to $40 million after receiving $95 million in applications, reflecting robust support from retail investors. Approximately 5 million new shares will be issued at $8.00 each, matching recent institutional pricing.

Woodside Energy has exercised its pre-emption right to acquire PetroChina's 10.67% interest in the Browse Joint Venture, increasing its stake to 41.27%. The deal includes a $225 million upfront payment and a $175 million contingent payment tied to a final investment decision by 2032.

Vitrafy Life Sciences has secured A$30 million through an institutional placement to ramp up manufacturing of its Guardion cryopreservation devices and expand US sales operations, with an additional A$2 million sought via a shareholder plan.

White Cliff Minerals finalises sale of Great Bear Project, receiving A$1.2 million cash and 230 million Great Bear Exploration shares while retaining near 10% stake.

Solstice Minerals has pushed the known limits of its Nanadie Copper-Gold Project with Phase 2 drilling confirming mineralisation 160m beyond the 2022 resource boundary and over a 1.2km strike length. The ongoing campaign includes diamond tails probing depth extensions, with assays pending to quantify promising visual sulphide zones.

MRG Metals has lodged a key Mining Right Conversion Application in South Africa for its Garies Rare Earth Project, setting the stage for scalable mining development supported by strong metallurgical results and a modular processing approach.

TZ Limited has voluntarily suspended trading of its shares on the ASX as it prepares to announce a significant capital raising. The suspension aims to ensure compliance with disclosure rules while the transaction is finalised.

Reach Resources has locked in $6.05 million in fresh capital, including a $2 million option fee from Andel Resources, positioning the company to accelerate development at its Murchison South gold project.

Neurizon Therapeutics has dosed over 50% of participants in the HEALEY ALS Platform Trial's Regimen I, exceeding recruitment expectations after expanding the cohort from 160 to 240 patients. The accelerated pace puts the company on track for last patient dosing in Q2 2027 and topline results by early Q3 2027.

Echo IQ has partnered with Mayo Clinic to assess its AI platform's ability to predict heart failure risk in patients undergoing cancer therapy, targeting the growing cardio-oncology sector.

Aldoro Resources has delivered standout assay results from its Phase II drilling at the Kameelburg Project in Namibia, highlighting extensive high-grade rare earth elements, strontium, and niobium mineralisation that underpin a robust multi-commodity deposit.

Quantum Graphite Limited has secured a binding Ore Supply Agreement with Sunlands Pure Group, consolidating downstream graphite processing and refining under a 20-year exclusive partnership. The deal sets ambitious production targets and pricing safeguards, underpinning Quantum's strategy to scale purified graphite supply for battery anodes and thermal storage markets.